Produk & keunggulan
MatwingsVenus™：Lightweight AI Biological Design Platform
MatwingsVenus™ is a lightweight AI biological design platform independently developed by Matwings . It pioneers an intelligent R&D paradigm of "design-as-validation, validation-as-iteration." The platform has already delivered multiple benchmark application cases in core sectors such as innovative therapeutics and synthetic biology. It was also selected for the "Treasure of the Pavilion" honors at WAIC 2026 (World Artificial Intelligence Conference 2026), where it was the only AI4S (AI for Science) product named to that year's list. Its foundation model, VenusREM, has long held the top position on the ProteinGym benchmark from Harvard Medical School, and in Harvard University's latest preprint PG-LLM evaluation, it has become the authoritative reference benchmark for the protein mutation prediction industry. The platform deeply integrates a database of tens of billions of real protein annotation records, 500+ professional protein design tools, and 60+ Skills tuned by domain experts, and brings together 50+ certified experts. Through natural-language conversation, users can direct the agent to carry out a wide range of core protein R&D tasks—including deep research, database retrieval, and protein design (e.g., enzyme mining, directed evolution, and de novo design)—while also supporting one-click ordering of automated wet-lab services for rapid experimental validation of proposed designs. The platform's complementary expert consulting services further provide users with authoritative guidance and optimization recommendations.
Semaglutide Intermediate P29
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, widely used in the management of type 2 diabetes and obesity. The 29-amino-acid backbone intermediate is a key raw material for semaglutide synthesis, directly influencing the quality of subsequent modifications, purification, and large-scale production. This intermediate can be produced via chemical synthesis or fermentation; the product described herein is manufactured via fermentation.
Nexligos™ Protein A Alkali
Nexligos™ Protein A Alkali features an alkali-stabilized recombinant Protein A ligand engineered by the protein R&D AI agent MatwingsVenus™ , and is suitable for monoclonal antibody (mAb) purification. Under the alkaline conditions employed during clean-in-place (CIP) and sanitization, this ligand demonstrates superior stability compared to conventional Protein A affinity resins and withstands stringent CIP and sanitization procedures using 0.1 to 0.5 M NaOH.
FYVE™ Lactulose Lime
Traditional lactulose products on the market contain absorbable monosaccharides, making them unsafe for people with diabetes to use with confidence. Our proprietary product contains zero absorbable monosaccharides and carries no risk of raising blood glucose.
aiselotech Kombucha
Brewed using a traditional fermentation method with a Jinjunmei-grade Congou black tea base, this kombucha is made from 85% raw fermented tea with 15% carbonation. It captures the natural aroma of the original tea infusion and delivers a crisp, sparkling mouthfeel—genuinely fermented from real tea, not reconstituted.